United States set
language
Menu Shopping cart $0 Search

References to miR-155-5p

  • Xiaoyan W. et al. "MicroRNA-155: a Novel Armamentarium Against Inflammatory Diseases." Inflammation; 40 (2): 708–716 (2017).
  • Wan J. Xia L. Xu Wand Lu N. "Expression and Function of miR-155 in Diseases of the Gastrointestinal Tract." Int. J. Mol. Sci.; 17. 709 (2016).
  • Faraon I. Antonetti FR. Cardone J. Bonmassar E. "miR-155 gene: A typical multifunctional microRNA. Biochim. Biophys." Acta; 1792: 497–505 (2009).
  • Papageorgiou SG. Kontos CK. Diamantopoulos MA. Bouchla A. Glezou E. Bazani E. Pappa V. Scorilas A. "MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel. Independent Molecular Biomarker of Poor Prognosis." Disease Markers; (2017).
  • Rodriguez A. Vigorito E. Clare S. et al.. “Requirement of bic/microRNA-155 for normal immune function.” Science; 316 (5824): 608–611 (2007).
  • Volinia S. Calin GA. Liu CG. et al. "A microRNA expression signature of human solid tumors defines cancer gene targets". Proc. Natl. Acad. Sci.;103:2257–2261 (2006).
  • Iorio MV. Ferracin M. Liu CG. et al. "MicroRNA gene expression deregulation in human breast cancer". Cancer Res.; 65: 7065–7070 (2005).
  • Nikiforova MN. Tseng GC. Steward D. et al. "MicroRNA expression profiling of thyroid tumors: Biological significance and diagnostic utility". J.Clin. Endocrinol. Metab.; 93: 1600–1608 (2008).
  • Wang. X. Tang S. Le S-Y. et al. "Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth". PLoS ONE; (2008).
  • Szafranska AE. Davison TS. John J. et al. "MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma". Oncogene; 26: 4442–4452 (2007).
  • Pagotto S. Veronese A. Soranno A. et al. "Hsa-miR-155-5p drives aneuploidy at early stages of cellular transformation ". Oncotarget; 9 (16): 13036-13047 (2018).
  • Ranganath P. "MicroRNA-155 and its role in malignant hematopoiesis". Biomark. Insights; 10: 95–102 (2015).